BRIGHTEN OPTIX CORPORATION Brighten Optix Corporation Stock
Equities
6747
TW0006747009
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 175.5 TWD | +1.15% |
|
+4.15% | -7.39% |
| Sales 2022 | 744M 22.98M | Sales 2023 | 747M 23.07M | Capitalization | 4.58B 142M |
|---|---|---|---|---|---|
| Net income 2022 | 256M 7.9M | Net income 2023 | 199M 6.14M | EV / Sales 2022 | 5.23 x |
| Net cash position 2022 | 620M 19.14M | Net cash position 2023 | 494M 15.26M | EV / Sales 2023 | 5.47 x |
| P/E ratio 2022 |
17.7
x | P/E ratio 2023 |
23.1
x | Employees | - |
| Yield 2022 |
4.88% | Yield 2023 |
2.83% | Free-Float | 33.42% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.15% | ||
| 1 week | +4.15% | ||
| Current month | +4.15% | ||
| 1 month | -1.13% | ||
| 3 months | -6.65% | ||
| 6 months | -7.39% | ||
| Current year | -7.39% |
1 week
170.00
176.00
1 month
167.50178.00
Current year
167.50194.00
1 year
167.50239.50
3 years
163.00479.50
5 years
72.00479.50
10 years
72.00479.50
| Managers | Title | Age | Since |
|---|---|---|---|
Tai Hsiung Wu
CEO | Chief Executive Officer | - | 76-04-30 |
Chu Yin Yeh
DFI | Director of Finance/CFO | - | - |
Yi Tsung Wu
CTO | Chief Tech/Sci/R&D Officer | - | 15-01-27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shih Fang Chiu
BRD | Director/Board Member | - | 19-09-19 |
Che Yu Li
BRD | Director/Board Member | - | 19-09-19 |
Tai Hsiung Wu
CEO | Chief Executive Officer | - | 76-04-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-05 | 175.5 | +1.15% | 17,313 |
| 24-07-04 | 173.5 | +0.29% | 13,923 |
| 24-07-03 | 173 | +0.87% | 30,881 |
| 24-07-02 | 171.5 | +0.29% | 8,101 |
| 24-07-01 | 171 | +1.48% | 17,198 |
End-of-day quote Taipei Exchange, July 04, 2024
More quotes
BRIGHTEN OPTIX CORPORATION is a Taiwan-based company principally engaged in the manufacture and sale of contact lenses. The Company is engaged in the manufacture of custom-made hard contact lenses, custom-made soft contact lenses, as well as the agency, distribution and sale of contact lens care products. The custom-made hard contact lenses include Rigid Gas-Permeable Lens and Orthokeratology Lenses. The Company distributes its products mainly in China.
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.39% | 131M | |
| +21.91% | 44.08B | |
| -9.21% | 17.1B | |
| -31.67% | 1.9B | |
| +11.49% | 1.87B | |
| +8.70% | 1.04B | |
| -8.84% | 659M | |
| +64.31% | 633M | |
| -45.94% | 625M | |
| -44.70% | 616M |
- Stock Market
- Equities
- 6747 Stock
